Janssen Pharmaceuticals, Inc.
Recent News About Janssen Pharmaceuticals, Inc.
-
Oklahoma judge feeds the 'monster' with $572M opioid ruling against Johnson & Johnson
Sixteen years ago in a case involving gunmaker Sturm, Ruger & Co., a New York appeals court refused to apply public nuisance law against the manufacturer of a legal product, saying that doing so would transform nuisance law “into a monster that would devour in one gulp the entire law of tort.” -
Private lawyers stand to make $90 million as judge hits Johnson & Johnson with $572M opioid ruling
NORMAN, Okla. (Legal Newsline) - A state judge in Oklahoma has blamed Johnson & Johnson for the state's opioid crisis and ordered it to pay $572 million in damages, extending public nuisance law beyond its traditional boundaries into what may become an all-purpose tool for government lawsuits against product manufacturers. -
Judge denies motion to reconsider sending Risperdal claims to state court
U.S. District Judge Ronnie White has denied a defense motion to reconsider a prior ruling that allowed Risperdal claims of 72 plaintiffs from 24 states to stay in state court. -
Judge says Janssen Pharmaceuticals case must stay in state court
ST. LOUIS — Another judge has rejected defense arguments for moving product liability claims out of state court and into federal court.